Stocktoria
AtriCure, Inc. ATRC
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2005-08-05
AtriCure, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 75.0% | 74.7% | 75.2% | 74.4% | 75.0% |
| Operating margin | -1.8% | -8.6% | -6.7% | -12.9% | 20.1% |
| Net margin | -2.1% | -9.6% | -7.6% | -14.1% | 18.3% |
| FCF margin | 9.0% | 0.2% | -1.9% | -11.8% | -8.6% |
| Return on assets | -1.7% | -7.3% | -5.0% | -7.9% | 8.2% |
| Return on equity | -2.3% | -9.7% | -6.5% | -10.2% | 10.4% |
| Debt / equity | 0.13× | 0.13× | 0.13× | 0.13× | 0.12× |
| Current ratio | 3.96 | 3.65 | 3.57 | 3.69 | 3.47 |
| Revenue growth | 14.9% | 16.5% | 20.8% | 20.4% | 32.8% |
Source: SEC EDGAR filings · CIK 0001323885 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.